Academic Article RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-κB activity in human keratinocytes
• 20-hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-κB activity by increasing IκBα levels in human keratinocytes
• 20-Hydroxyvitamin D 3 inhibits proliferation of cancer cells with high efficacy while being non-toxic
• 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells
• 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation
• 20-Year-Old Amish Woman With Abdominal Pain, Retroperitoneal Mass, and Hyperlipidemia
• 2003 Congress of Neurological Surgeons presidential address. The value of neurosurgery.
• 2004 AONE award winner profiles: Organizational innovation in nursing leadership
• 2005 AONE award winner profiles: Nurse executive scholarship
• 2007 Guideline for the Management of Ureteral Calculi
• 2007 Guideline for the Management of Ureteral Calculi
• 2008 ACLPS panel discussion on resident education in clinical pathology
• 2010 Accounting Program Annual Report
• 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.
• 2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
• 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.
• 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
• 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
• 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
• 2013 Dahl Lecture American heart association council for high blood pressure research clarifying the physiology of endothelin
• 2013 European society of hypertension/European society of cardiology hypertension guidelines
• 2013 Update of the 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
• 2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
• 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (JNC 8)
• 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
• 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
• 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
• 2015 SNMMI highlights lecture: General nuclear medicine

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...